Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/73252
| Title: | KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? | Authors: | Rodríguez Abreu, D. Garassino, M. C. Esteban, E. Speranza, G. Felip, E. Domine, M. Hochmair, M. J. Powell, S. Cheng, S. Y-S. Bischoff, H. G. Peled, N. Hui, R. Reck, M. Garon, E. B. Boyer, M. Grossi, F. Jennens, R. Yang, J. Pietanza, M. C. Gadgeel, S. |
UNESCO Clasification: | 320101 Oncología | Issue Date: | 2018 | Journal: | Annals of Oncology | Conference: | European-Society-for-Medical-Oncology Asia Congress | URI: | http://hdl.handle.net/10553/73252 | ISSN: | 0923-7534 | Source: | Annals of Oncology [ISSN 0923-7534], v. 29 (sup. 9), p. 164, Abstract 532P, (Noviembre 2018) |
| Appears in Collections: | Actas de congresos |
Adobe PDF (62,49 kB)
WEB OF SCIENCETM
Citations
3
checked on Feb 25, 2024
Page view(s)
54
checked on Feb 3, 2024
Download(s)
133
checked on Feb 3, 2024
Google ScholarTM
Check
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.